Fortis Healthcare Sees Sharp Open Interest Surge Amid Rising Market Momentum

Open Interest Spike and Volume Dynamics

On 26 Feb 2026, Fortis Healthcare’s open interest (OI) in derivatives rose sharply to 20,542 contracts, up 22.35% from the previous day’s 16,789. This increase of 3,753 contracts is notable given the stock’s underlying price movement and volume patterns. The total traded volume in derivatives stood at 24,846 contracts, indicating robust participation in both futures and options segments.

The futures segment alone accounted for a value of approximately ₹30,197 lakhs, while the options segment’s notional value was substantially higher at ₹15,929.44 crores. The combined derivatives turnover reached ₹34,519 lakhs, underscoring the stock’s liquidity and attractiveness for active trading strategies.

Price Performance and Moving Averages

Fortis Healthcare’s underlying stock price closed at ₹955, having touched an intraday high of ₹961.4, marking a 3.29% gain on the day. This performance outpaced the hospital sector’s 0.30% gain and the Sensex’s marginal 0.05% rise, reflecting relative strength. The stock has recorded gains for two consecutive sessions, delivering a cumulative return of 4.2% over this period.

Technically, Fortis is trading above all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling a sustained uptrend and positive momentum. Such alignment of moving averages often attracts momentum traders and institutional investors, further supporting the price advance.

Investor Participation and Delivery Volumes

Investor participation has surged notably, with delivery volumes on 25 Feb reaching 11.05 lakh shares, a remarkable 116.75% increase over the five-day average delivery volume. This indicates that a larger proportion of investors are holding shares rather than trading intraday, a sign of conviction in the stock’s prospects.

Liquidity remains ample, with the stock’s average traded value over five days supporting trade sizes up to ₹2.21 crore without significant market impact. This liquidity profile is favourable for both retail and institutional investors looking to build or exit positions efficiently.

Market Positioning and Directional Bets

The sharp rise in open interest alongside increasing volumes suggests that market participants are actively repositioning themselves in Fortis Healthcare derivatives. The 22.35% jump in OI, coupled with a 3.28% day change in the stock price, points to fresh long positions being established or short positions being covered.

Given the stock’s outperformance relative to its sector and the Sensex, it is plausible that traders are betting on continued upward momentum. The futures value of ₹30,197 lakhs and the substantial options notional value indicate that both outright directional bets and hedging strategies are in play.

Options activity, with a notional value exceeding ₹15,929 crores, may reflect increased interest in call options, which typically benefit from bullish outlooks. However, without detailed strike-wise data, it is prudent to consider that some participants may also be employing complex strategies such as spreads or collars to manage risk amid volatility.

Mojo Score and Analyst Ratings

Fortis Healthcare currently holds a Mojo Score of 51.0, categorised as a Hold rating. This represents a downgrade from a previous Buy rating as of 13 Jan 2025, signalling a more cautious stance from analysts. The market cap grade stands at 2, reflecting its mid-cap status with moderate liquidity and market presence.

Despite the recent positive price action and volume surge, the Hold rating suggests that investors should weigh the stock’s valuation and sector dynamics carefully. The hospital sector faces ongoing challenges including regulatory pressures and competitive intensity, which may temper upside potential in the near term.

Sector and Market Context

The hospital sector has shown modest gains recently, with Fortis Healthcare outperforming peers by 2.72% on the day. This relative strength may be driven by company-specific developments, improved operational metrics, or favourable market sentiment towards healthcare services amid evolving demand patterns.

Fortis’s market capitalisation stands at ₹71,834 crore, positioning it as a significant mid-cap player within the hospital industry. Its liquidity profile and rising investor interest make it a key stock to watch for sector rotation and thematic investment flows.

Implications for Investors

The recent surge in open interest and volume in Fortis Healthcare derivatives highlights a phase of active repositioning and heightened market interest. Investors should monitor whether this momentum sustains, especially as the stock trades above all major moving averages and delivery volumes rise sharply.

However, the Hold rating and mid-cap classification advise caution. Potential investors ought to consider broader sector trends, regulatory developments, and valuation metrics before committing fresh capital. The derivatives activity may offer clues on short-term directional bets, but longer-term fundamentals remain critical.

For traders, the liquidity and volume profile support tactical entries and exits, while the options market activity could provide opportunities for hedging or speculative strategies aligned with the stock’s momentum.

Conclusion

Fortis Healthcare Ltd’s recent open interest surge in derivatives, combined with strong price performance and rising investor participation, signals a bullish tilt in market sentiment. While the stock outperforms its sector and broader indices, the Hold rating and mid-cap status counsel measured optimism. Investors and traders should closely track volume patterns, price action, and sector developments to capitalise on emerging opportunities while managing risks prudently.

Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →